Perion Network (NASDAQ:PERI – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, November 6th. Analysts expect Perion Network to post earnings of $0.22 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Perion Network Trading Up 1.0 %
NASDAQ PERI opened at $8.29 on Tuesday. The company has a fifty day simple moving average of $8.11 and a two-hundred day simple moving average of $9.32. The stock has a market cap of $392.20 million, a P/E ratio of 5.36, a P/E/G ratio of 0.41 and a beta of 1.47. Perion Network has a 12-month low of $7.47 and a 12-month high of $32.99.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Lake Street Capital raised shares of Perion Network from a “hold” rating to a “buy” rating and set a $10.00 price target for the company in a report on Wednesday, July 31st. Stifel Nicolaus decreased their price target on shares of Perion Network from $9.00 to $7.50 and set a “hold” rating for the company in a report on Monday, October 14th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Perion Network in a report on Thursday, August 1st. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $12.13.
Perion Network Company Profile
Perion Network Ltd. provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally. It offers Wildfire, a content monetization platform; search monetization solutions, including website monetization, search mediation, and app monetization; and cross-channel digital advertising software as a service platform.
See Also
- Five stocks we like better than Perion Network
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Intel: Is Now the Time to Be Brave?Â
- What is an Earnings Surprise?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Buy P&G Now, Before It Sets A New All-Time High
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Perion Network Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perion Network and related companies with MarketBeat.com's FREE daily email newsletter.